165 related articles for article (PubMed ID: 36387263)
1. Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients.
Duca RB; Massillo C; Farré PL; Graña KD; Moro J; Gardner K; Lacunza E; De Siervi A
Front Oncol; 2022; 12():997457. PubMed ID: 36387263
[TBL] [Abstract][Full Text] [Related]
2. MiR-19b-3p and miR-101-3p as potential biomarkers for prostate cancer diagnosis and prognosis.
Duca RB; Massillo C; Dalton GN; Farré PL; Graña KD; Gardner K; De Siervi A
Am J Cancer Res; 2021; 11(6):2802-2820. PubMed ID: 34249429
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue from metabolic syndrome mice induces an aberrant miRNA signature highly relevant in prostate cancer development.
Massillo C; Duca RB; Lacunza E; Dalton GN; Farré PL; Taha N; Piccioni F; Scalise GD; Gardner K; De Siervi A
Mol Oncol; 2020 Nov; 14(11):2868-2883. PubMed ID: 32875710
[TBL] [Abstract][Full Text] [Related]
5. microRNA Expression Profiling in Young Prostate Cancer Patients.
Valera VA; Parra-Medina R; Walter BA; Pinto P; Merino MJ
J Cancer; 2020; 11(14):4106-4114. PubMed ID: 32368293
[TBL] [Abstract][Full Text] [Related]
6. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.
Lin Y; Miao Z; Zhang X; Wei X; Hou J; Huang Y; Shen B
Front Genet; 2020; 11():596826. PubMed ID: 33519899
[No Abstract] [Full Text] [Related]
7. Extensive screening of microRNA populations identifies hsa-miR-375 and hsa-miR-133a-3p as selective markers for human rectal and colon cancer.
Weber D; Amar L; Gödde D; Prinz C
Oncotarget; 2018 Jun; 9(43):27256-27267. PubMed ID: 29930763
[TBL] [Abstract][Full Text] [Related]
8. Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer.
Crimi S; Falzone L; Gattuso G; Grillo CM; Candido S; Bianchi A; Libra M
Biology (Basel); 2020 Nov; 9(11):. PubMed ID: 33172167
[TBL] [Abstract][Full Text] [Related]
9. Exosome-Derived miRNAs as Potential Biomarkers for Prostate Bone Metastasis.
Lu Z; Hou J; Li X; Zhou J; Luo B; Liang S; Lo RK; Wong TM; Kuang GM
Int J Gen Med; 2022; 15():5369-5383. PubMed ID: 35673634
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population.
Zhang N; Wang J; Zhang S; Wu H; Li Z; Hu M
Biomarkers; 2023 Jun; 28(4):372-378. PubMed ID: 37185057
[TBL] [Abstract][Full Text] [Related]
11. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
12. An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer.
Fort RS; Mathó C; Oliveira-Rizzo C; Garat B; Sotelo-Silveira JR; Duhagon MA
Exp Hematol Oncol; 2018; 7():10. PubMed ID: 29744254
[TBL] [Abstract][Full Text] [Related]
13. Determination of miRNA expression profile in patients with prostate cancer and benign prostate hyperplasia.
Sancer O; Koşar PA; Tefebaşı MY; Ergün O; Demir M; Koşar A
Turk J Med Sci; 2022 Jun; 52(3):788-795. PubMed ID: 36326314
[TBL] [Abstract][Full Text] [Related]
14. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
15. Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics Analysis.
Wu YP; Lin XD; Chen SH; Ke ZB; Lin F; Chen DN; Xue XY; Wei Y; Zheng QS; Wen YA; Xu N
Front Genet; 2020; 11():892. PubMed ID: 32922436
[TBL] [Abstract][Full Text] [Related]
16. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.
Chiyomaru T; Yamamura S; Fukuhara S; Hidaka H; Majid S; Saini S; Arora S; Deng G; Shahryari V; Chang I; Tanaka Y; Tabatabai ZL; Enokida H; Seki N; Nakagawa M; Dahiya R
PLoS One; 2013; 8(3):e58929. PubMed ID: 23554959
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes.
Ntoumou E; Tzetis M; Braoudaki M; Lambrou G; Poulou M; Malizos K; Stefanou N; Anastasopoulou L; Tsezou A
Clin Epigenetics; 2017; 9():127. PubMed ID: 29255496
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188-3p/ARID5B/AR axis in prostate carcinoma.
Chen Z; Fu S; Shan Y; Li H; Wang H; Liu J; Wang W; Huang Y; Huang H; Wang J; Ding M
Pathol Res Pract; 2022 Sep; 237():154052. PubMed ID: 35939970
[TBL] [Abstract][Full Text] [Related]
19. Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3A positive feedback loop.
Shi W; Tang T; Li X; Deng S; Li R; Wang Y; Wang Y; Xia T; Zhang Y; Zen K; Jin L; Pan Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):429. PubMed ID: 31660998
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA/mRNA profiling and regulatory network of intracranial aneurysm.
Jiang Y; Zhang M; He H; Chen J; Zeng H; Li J; Duan R
BMC Med Genomics; 2013 Sep; 6():36. PubMed ID: 24079748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
